GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » ROE % Adjusted to Book Value

Remus Pharmaceuticals (NSE:REMUS) ROE % Adjusted to Book Value : 1.95% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals ROE % Adjusted to Book Value?

Remus Pharmaceuticals's ROE % for the quarter that ended in Sep. 2024 was 29.92%. Remus Pharmaceuticals's PB Ratio for the quarter that ended in Sep. 2024 was 15.36. Remus Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 1.95%.


Remus Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Remus Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals ROE % Adjusted to Book Value Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
ROE % Adjusted to Book Value
- - - 3.95

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - 2.76 3.43 1.95

Competitive Comparison of Remus Pharmaceuticals's ROE % Adjusted to Book Value

For the Medical Distribution subindustry, Remus Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's ROE % Adjusted to Book Value falls into.



Remus Pharmaceuticals ROE % Adjusted to Book Value Calculation

Remus Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=46.17% / 11.70
=3.95%

Remus Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=29.92% / 15.36
=1.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remus Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines